Clinical Trials Browser

NIH × Sarcoma × Sorafenib × Clear all

NCT00245102 2014-05-23

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

Phase 2 Completed

147 enrolled 13 charts

Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00217620 2014-05-15

S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas

Phase 2 Completed

51 enrolled 9 charts

Hemangiopericytoma, Malignant, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma

NCT00330421 2014-04-30

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Phase 2 Completed

15 enrolled 7 charts

Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00874874 2009-12-24

Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery

Phase 2 Unknown

Hemangiosarcoma, Sarcoma